AAAAAA
Results:
1-7
|
Results: 7
Authors:
Pestelli, E
Caproni, M
Giomi, B
Volpi, W
Spallanzani, A
Cardinal, C
Floriani, J
Fabbri, P
Citation: E. Pestelli et al., Cetirizine reduces the number of tryptase-positive mast cells in psoriaticpatients: A double-blind controlled study, INT J TISS, 23(3), 2001, pp. 97-103
Authors:
Moretti, S
Spallanzani, A
Chiarugi, A
Fabiani, M
Pinzi, C
Citation: S. Moretti et al., Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: Different correlation according to thickness, J AM ACAD D, 44(2), 2001, pp. 188-192
Authors:
Moretti, S
Spallanzani, A
Chiarugi, A
Muscarella, G
Battini, ML
Citation: S. Moretti et al., Oral carcinoma in a young man: a case of dyskeratosis congenita, J EUR A D V, 14(2), 2000, pp. 123-125
Authors:
Ghersetich, I
Spallanzani, A
Bianchi, B
Lotti, TM
Citation: I. Ghersetich et al., Collagen vascular diseases: Unapproved treatments or indications, CLIN DERMAT, 18(2), 2000, pp. 187-190
Authors:
Lotti, TM
Menchini, G
Spallanzani, A
Moretti, S
Ghersetich, I
Bianchi, B
Citation: Tm. Lotti et al., Arachidonate transforming and immunomodulating agents: Unapproved uses or indications, CLIN DERMAT, 18(1), 2000, pp. 119-123
Authors:
Moretti, S
Spallanzani, A
Pinzi, C
Citation: S. Moretti et al., Skin angiogenesis: Biologic bases for pathological processes, CLIN DERMAT, 17(6), 1999, pp. 629-631
Authors:
Moretti, S
Pinzi, C
Spallanzani, A
Berti, E
Chiarugi, A
Mazzoli, S
Fabiani, M
Vallecchi, C
Herlyn, M
Citation: S. Moretti et al., Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions, INT J CANC, 84(2), 1999, pp. 160-168
Risultati:
1-7
|